对抗体度比率的诊断值治疗不耐药的严重肌痛性肌痛症
Yi Li1, Shumei Yang2, Xiaohua Dong1
1Department of Neurology, Research Center for Neuroimmune and Neuromuscular disorders, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410000, Hunan, China.
概括
抗体度比显示了诊断潜力,用于识别耐火性肌痛性肌痛症 (MG). 较高的比率与耐火MG有关,这表明它可以用作生物标志物.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 骨髓灰质炎 (MG) 是一种自身免疫性疾病,影响神经肌肉结节.
- 识别治疗不耐药的MG对于有效的患者管理至关重要.
- 目前的诊断方法可能无法完全捕捉治疗反应细微差别.
研究的目的:
- 评估抗体度比 (ACR) 的诊断实用性,用于识别不耐治疗的严重肌痛性肌痛症 (MG).
- 确定ACR是否可以作为耐火性MG的可靠生物标志物.
- 评估ACR和MG治疗结果之间的相关性.
主要方法:
- 追溯分析116名MG患者的连续抗体检测.
- 计算抗体度比 (ACR) 以评估治疗反应.
- 使用接收器操作特征 (ROC) 曲线分析,评估诊断疗效,敏感性,特异性和准确性.
主要成果:
- 在116名患者中,有19名患者被诊断为耐火性MG.
- 在ACR和耐火性MG状态之间观察到显著的相关性.
- 该ACR证明了耐火MG的强大诊断能力,曲线下的面积 (AUC) 为0.8709.
结论:
- 抗体度比率升高与耐火性MG密切相关.
- ACR显示出作为耐火性MG的诊断生物标志物具有显著的潜力.
- 这个比率可能有助于区分耐火病例和指导治疗策略.
相关概念视频
01:15Myasthenia Gravis: Diagnostic Tests
782
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
782
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K